|
Volumn 98, Issue 3, 2001, Pages 525-538
|
Gestational diabetes
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDIABETIC AGENT;
GLIBENCLAMIDE;
INSULIN;
INSULIN LISPRO;
SULFONYLUREA DERIVATIVE;
BLOOD GLUCOSE MONITORING;
BLOOD SAMPLING;
CESAREAN SECTION;
CLINICAL FEATURE;
CLINICAL RESEARCH;
CLINICAL TRIAL;
DIABETIC DIET;
DIAGNOSTIC PROCEDURE;
FETUS OUTCOME;
GESTATIONAL AGE;
HUMAN;
HYPERINSULINEMIA;
INSULIN TREATMENT;
KINESIOTHERAPY;
MATERNAL DIABETES MELLITUS;
PATIENT CARE;
PREGNANCY COMPLICATION;
PREVALENCE;
PRIORITY JOURNAL;
PUERPERIUM;
REVIEW;
RISK FACTOR;
SCREENING TEST;
TERATOGENICITY;
TREATMENT OUTCOME;
ARTICLE;
DIET THERAPY;
FEMALE;
GLUCOSE BLOOD LEVEL;
MONITORING;
PRACTICE GUIDELINE;
PREGNANCY;
PREGNANCY DIABETES MELLITUS;
BLOOD GLUCOSE;
DIABETES, GESTATIONAL;
EXERCISE THERAPY;
FEMALE;
GESTATIONAL AGE;
HUMANS;
MONITORING, PHYSIOLOGIC;
PREGNANCY;
RISK FACTORS;
|
EID: 0034832156
PISSN: 00297844
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (639)
|
References (105)
|